Differential Diagnosis and Workup for Heavy Irregular Menses with Systemic Symptoms
This 50-year-old woman most likely has iron deficiency anemia secondary to heavy menstrual bleeding, and requires immediate serum ferritin testing (using ≤50 ng/mL threshold given her heavy bleeding), complete blood count, thyroid function tests, and transvaginal ultrasound to identify structural uterine pathology.
Primary Differential Diagnosis
The constellation of heavy irregular menses, hair loss, fatigue, and muscle aches/cramps in a perimenopausal woman points to three interconnected diagnostic categories:
1. Iron Deficiency Anemia (Most Likely)
- Heavy menstrual bleeding is the leading cause of iron deficiency in menstruating individuals 1
- For women with heavy menstrual bleeding, use serum ferritin ≤50 ng/mL as the diagnostic threshold (not the standard ≤30 ng/mL threshold) 1
- Fatigue, hair loss, and muscle symptoms are classic manifestations of iron deficiency
- Global prevalence of iron deficiency in menstruating individuals is 27% 1
2. Structural Uterine Pathology
At age 50, the most common structural causes are:
- Endometrial polyps (most common above age 40) 2
- Leiomyomas/fibroids (more common under age 40 but still prevalent) 2
- Adenomyosis 3
- Endometrial hyperplasia or malignancy (critical to exclude in this age group) 4
3. Thyroid Dysfunction
- Hypothyroidism causes both menorrhagia and the systemic symptoms described (fatigue, hair loss, muscle aches/cramps) 4, 5
- Must be ruled out as it's a treatable cause of both bleeding and systemic symptoms
4. Bleeding Disorder
- Present in 10-62% of women with heavy menstrual bleeding 6
- Von Willebrand disease is the most common 4
- Significantly underdiagnosed in gynecology practice 6
Recommended Workup Algorithm
Immediate Laboratory Testing:
Complete blood count - assess for anemia 7
Serum ferritin with ≤50 ng/mL threshold - This higher threshold is specifically recommended for women with heavy menstrual bleeding 1. The standard ≤30 ng/mL threshold is insufficient for this population.
Thyroid-stimulating hormone (TSH) - thyroid dysfunction is a common reversible cause 4, 5
Pregnancy test - mandatory in any reproductive-age woman with abnormal bleeding, even at age 50 7
Bleeding Disorder Screening (if indicated):
Consider hemostatic evaluation if she reports:
- Clots ≥1 inch diameter 5
- "Flooding" (changing pad/tampon more frequently than hourly) 5
- Personal or family history of bleeding problems 5
- Prolonged menses (>7 days) 5
If positive screening, obtain:
Imaging:
Transvaginal ultrasound is the first-line imaging study 3, 8, 2
- Evaluates for fibroids, polyps, adenomyosis, endometrial thickness
- If endometrium cannot be completely visualized due to fibroids or adenomyosis, proceed to MRI with diffusion-weighted imaging 3
Endometrial Sampling:
This patient requires endometrial biopsy based on:
Perform endometrial biopsy to exclude:
- Endometrial hyperplasia
- Endometrial carcinoma
- Endometrial polyps (though less sensitive than hysteroscopy) 2
Critical Clinical Pitfalls
Don't Use the Wrong Ferritin Threshold
The ASH 2026 guidelines explicitly state that women with heavy menstrual bleeding require the ≤50 ng/mL threshold, not ≤30 ng/mL or ≤15 ng/mL 1. Using lower thresholds will miss iron deficiency in this population.
Don't Skip Endometrial Assessment
At age 50 with irregular bleeding, endometrial cancer risk is elevated. Failure to obtain tissue diagnosis is a major pitfall 4. Even if ultrasound shows fibroids, this doesn't exclude concurrent endometrial pathology.
Don't Overlook Bleeding Disorders
Up to 62% of women with heavy menstrual bleeding have an underlying bleeding disorder, yet these are massively underdiagnosed in gynecology practice 6. Use the clinical screening criteria (flooding, large clots, family history) to identify who needs hematology referral 5.
Don't Assume Perimenopause Explains Everything
While irregular cycles are expected at age 50, the combination with systemic symptoms demands investigation for thyroid disease, iron deficiency, and structural pathology 4.
Immediate Management Considerations
While awaiting workup results: